Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Receivables (2016 - 2026)

Conmed filings provide 17 years of Change in Receivables readings, the most recent being -$18.6 million for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 1.99% to -$18.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 million, a 114.99% increase, with the full-year FY2025 number at $2.4 million, up 45.83% from a year prior.
  • Change in Receivables hit -$18.6 million in Q1 2026 for Conmed, down from $22.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $22.7 million in Q4 2025 to a low of -$19.0 million in Q1 2025.
  • Median Change in Receivables over the past 5 years was $908000.0 (2024), compared with a mean of $2.2 million.
  • Biggest five-year swings in Change in Receivables: surged 12578.53% in 2023 and later crashed 2190.75% in 2025.
  • Conmed's Change in Receivables stood at -$10.9 million in 2022, then soared by 183.14% to $9.1 million in 2023, then surged by 36.97% to $12.4 million in 2024, then soared by 82.83% to $22.7 million in 2025, then crashed by 182.07% to -$18.6 million in 2026.
  • The last three reported values for Change in Receivables were -$18.6 million (Q1 2026), $22.7 million (Q4 2025), and -$9.2 million (Q3 2025) per Business Quant data.